MedPath

Levonorgestrel

These highlights do not include all the information needed to use Levonorgestrel safely and effectively. See full prescribing information for Levonorgestrel. Levonorgestrel (Levonorgestrel) TABLET for ORAL use.Initial U.S. Approval: 1982

Approved
Approval ID

d0bbb668-cc24-436b-9144-673a28b81f7d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 26, 2013

Manufacturers
FDA

Novel Laboratories, Inc.

DUNS: 793518643

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code40032-620
Application NumberANDA202508
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 26, 2013
FDA Product Classification

INGREDIENTS (6)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LEVONORGESTRELActive
Quantity: 1.5 mg in 1 1
Code: 5W7SIA7YZW
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levonorgestrel - FDA Drug Approval Details